Tagraxofusp
STML-401-0423
Phase 2 small_molecule active
Quick answer
Tagraxofusp for Acute Myeloid Leukemia is a Phase 2 program (small_molecule) at Stemline Therapeutics B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Stemline Therapeutics B.V.
- Indication
- Acute Myeloid Leukemia
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active